Harbin Gloria Pharmaceuticals Co Ltd (002437):企業の財務・戦略的SWOT分析

◆英語タイトル:Harbin Gloria Pharmaceuticals Co Ltd (002437) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH3242364FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:中国
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥88,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥133,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Harbin Gloria Pharmaceuticals Co Ltd (Harbin Gloria) is a pharmaceutical company that produces and markets nutritional drugs. The company’s products include pharmaceutical drugs for treating nutrition disorders, cancer, cardiovascular diseases, anti-tumor medication, respiratory medication, and musculoskeletal disorders. Its pipeline products include anti-infectives; and irritable bowel syndrome with constipation in women, lubiprostone, ropivacaine mesylate for injection, antihistamine, vitamins and minerals, sodium creatine phosphate for injection, bupixiaoji oral solution, annao and olmesartan medoxomil tablets. The company also collaborates with hospitals and institutions to carry out its research activities. Harbin Gloria is headquartered in Harbin, China.

Harbin Gloria Pharmaceuticals Co Ltd Key Recent Developments

Jan 26,2021: Gloria was awarded as “Excellent Partner of Biochemical and Biological Enterprises in 2020″

This comprehensive SWOT profile of Harbin Gloria Pharmaceuticals Co Ltd provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Harbin Gloria Pharmaceuticals Co Ltd including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Harbin Gloria Pharmaceuticals Co Ltd – Key Information
Harbin Gloria Pharmaceuticals Co Ltd – Overview
Harbin Gloria Pharmaceuticals Co Ltd – Key Employees
Harbin Gloria Pharmaceuticals Co Ltd – Key Employee Biographies
Harbin Gloria Pharmaceuticals Co Ltd – Key Operational Heads
Harbin Gloria Pharmaceuticals Co Ltd – Major Products and Services
Harbin Gloria Pharmaceuticals Co Ltd – History
Harbin Gloria Pharmaceuticals Co Ltd – Company Statement
Harbin Gloria Pharmaceuticals Co Ltd – Locations And Subsidiaries
Harbin Gloria Pharmaceuticals Co Ltd
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Harbin Gloria Pharmaceuticals Co Ltd – Business Description
Harbin Gloria Pharmaceuticals Co Ltd – Corporate Strategy
Harbin Gloria Pharmaceuticals Co Ltd – SWOT Analysis
SWOT Analysis – Overview
Harbin Gloria Pharmaceuticals Co Ltd – Strengths
Harbin Gloria Pharmaceuticals Co Ltd – Weaknesses
Harbin Gloria Pharmaceuticals Co Ltd – Opportunities
Harbin Gloria Pharmaceuticals Co Ltd – Threats
Harbin Gloria Pharmaceuticals Co Ltd – Key Competitors

Section 3 – Company Financial Performance Charts

Harbin Gloria Pharmaceuticals Co Ltd – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Harbin Gloria Pharmaceuticals Co Ltd, Key Information
Harbin Gloria Pharmaceuticals Co Ltd, Key Ratios
Harbin Gloria Pharmaceuticals Co Ltd, Share Data
Harbin Gloria Pharmaceuticals Co Ltd, Major Products and Services
Harbin Gloria Pharmaceuticals Co Ltd, History
Harbin Gloria Pharmaceuticals Co Ltd, Key Employees
Harbin Gloria Pharmaceuticals Co Ltd, Key Employee Biographies
Harbin Gloria Pharmaceuticals Co Ltd, Key Operational Heads
Harbin Gloria Pharmaceuticals Co Ltd, Other Locations
Harbin Gloria Pharmaceuticals Co Ltd, Subsidiaries
Harbin Gloria Pharmaceuticals Co Ltd, Key Competitors
Harbin Gloria Pharmaceuticals Co Ltd, SWOT Analysis
Harbin Gloria Pharmaceuticals Co Ltd, Ratios based on current share price
Harbin Gloria Pharmaceuticals Co Ltd, Annual Ratios
Harbin Gloria Pharmaceuticals Co Ltd, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Harbin Gloria Pharmaceuticals Co Ltd (002437):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Clark Enterprises Inc:企業の戦略・SWOT・財務分析
    Clark Enterprises Inc - Strategy, SWOT and Corporate Finance Report Summary Clark Enterprises Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • HOK Group, Inc.:企業の戦略・SWOT・財務情報
    HOK Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary HOK Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • PORR AG (POS):企業の財務・戦略的SWOT分析
    PORR AG (POS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • Martifer SGPS SA (MAR):企業の財務・戦略的SWOT分析
    Martifer SGPS SA (MAR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Sandoz International GmbH-製薬・医療分野:企業M&A・提携分析
    Summary Sandoz International GmbH (Sandoz), a subsidiary of Novartis AG develops, manufactures and commercializes generic pharmaceutical products. The company provides biosimilars, generic antibiotics, dermatology and transplantation medicines. Its biosimilars comprise Omnitrope, Binocrit and Zarzio …
  • Targa Resources Partners LP (NGLS PR A):石油・ガス:M&Aディール及び事業提携情報
    Summary Targa Resources Partners LP (Targa Resources) is an independent midstream company. It carries out the gathering, compressing, treating, processing and sale of natural gas, and storing, fractionating, treating, transporting and selling natural gas liquids (NGLs) and NGL products. The company …
  • William Hill plc (WMH):企業の財務・戦略的SWOT分析
    William Hill plc (WMH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Hoag Hospital Foundation:企業の戦略的SWOT分析
    Hoag Hospital Foundation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Asure Software, Inc. (ASUR):企業の財務・戦略的SWOT分析
    Asure Software, Inc. (ASUR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • The Ensign Group Inc (ENSG):製薬・医療:M&Aディール及び事業提携情報
    Summary The Ensign Group Inc (Ensign Group) is a healthcare service provider that offers patient care services. The organization offers post-acute care services including assisted living, skilled nursing, rehabilitative care, home health, home care, and hospice. It provides services such as medical, …
  • BioCision LLC-製薬・医療分野:企業M&A・提携分析
    Summary BioCision LLC (BioCision) is a life science research and development company that develops products and solutions for process standardization. The company’s products include cell cryopreservation systems, ice-free cooling systems, tube and plate temperature management systems, cell thawing s …
  • Huntsman Corp (HUN):企業の財務・戦略的SWOT分析
    Huntsman Corp (HUN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Hang Seng Bank Ltd:企業の戦略・SWOT・財務分析
    Hang Seng Bank Ltd - Strategy, SWOT and Corporate Finance Report Summary Hang Seng Bank Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • MLP SE (MLP):企業の財務・戦略的SWOT分析
    MLP SE (MLP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pote …
  • TeleTech Holdings, Inc. (TTEC):企業の財務・戦略的SWOT分析
    TeleTech Holdings, Inc. (TTEC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Astrazeneca Pharma India Ltd (ASTRAZEN):企業の財務・戦略的SWOT分析
    Summary AstraZeneca Pharma India Ltd (AstraZeneca), a subsidiary of AstraZeneca Plc, is a biopharmaceutical company. It discovers, develops, supplies and commercializes medicines. The company’s product portfolio include Forxiga, Imdur, Crestor, Tagrisso, Lynparza, Betaloc, Symbicort, budesonide, for …
  • Cosan Ltd:企業の戦略・SWOT・財務情報
    Cosan Ltd - Strategy, SWOT and Corporate Finance Report Summary Cosan Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • ROSEN Swiss AG:企業の戦略的SWOT分析
    ROSEN Swiss AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Transgene Biotek Ltd (526139):企業の財務・戦略的SWOT分析
    Summary Transgene Biotek Ltd (Transgene) is a biotechnology company that develops and commercializes bio-generic drugs and vaccines to treat autoimmune diseases and cancer. The company’s product portfolio includes TrabiDHA, a vegetarian source of DHA (Docosahexaenoic acid), used to manufacture healt …
  • Taiwan Power Co Ltd:電力:M&Aディール及び事業提携情報
    Summary Taiwan Power Company Ltd (Taiwan Power) is an integrated state-owned electric utility that offers electricity generation, transmission and distribution services. The utility generates electricity through various fuel resources including thermal, coal, gas, cogeneration and renewable sources. …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆